Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oncternal Therapeutics Inc (NQ: ONCT )

1.140 -0.020 (-1.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oncternal Therapeutics Inc

< Previous 1 2 3 4 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Looking Into Oncternal Therapeutics's Return On Capital Employed
Via Benzinga
Oncternal Therapeutics: Q1 Earnings Insights
Via Benzinga
Oncternal Therapeutics's Return On Capital Employed Overview
Via Benzinga
Earnings Scheduled For August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
Via Benzinga
Oncternal Therapeutics's Earnings Outlook
Via Benzinga
NN And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by over 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday. 
Via Benzinga
Oncternal Therapeutics's Return On Capital Employed Overview
Via Benzinga
Oncternal Therapeutics Announces Strategic Reprioritization, Stops Two Zilovertamab Studies
Oncternal Therapeutics Inc (NASDAQ: ONCT) will suspend Phase 3 and the Phase 1/2 studies of zilovertamab in combination with ibrutinib, citing the rapidly changing commercial landscape for Bruton's... 
Via Benzinga
Dow Tumbles Over 200 Points; Butterfly Network Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. The Dow traded down 0.64% to 33,387.61 while the NASDAQ fell 0.45% to 12,134.09. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Via Benzinga
Why Is Nogin (NOGN) Stock Down 61% Today?
Nogin (NOGN) stock is falling hard on Tuesday after the company revealed details about a public offering for its shares. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Oncternal Therapeutics (ONCT) Stock Down 62% Today?
Oncternal Therapeutics (ONCT) stock is falling hard on Tuesday after the company decided to end two clinical trials to switch focus. 
Via InvestorPlace
Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Gainers AMC Entertainment Hldg Pref Equity Units (NYSE: APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers for Tuesday morning with all the latest news traders need to know about! 
Via InvestorPlace
NVIDIA To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Wednesday
Oppenheimer cut the price target for Oncternal Therapeutics, Inc. (NASDAQ: ONCT) from $14 to $9. Oppenheimer analyst Hartaj Singh maintained an Outperform rating. Oncternal Therapeutics shares fell... 
Via Benzinga
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning! 
Via InvestorPlace
Recap: Oncternal Therapeutics Q2 Earnings
  Oncternal Therapeutics (NASDAQ:ONCT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Preview: Oncternal Therapeutics
  Oncternal Therapeutics (NASDAQ:ONCT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.